7.
Montuschi, P. (2007) Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Therapeutic Advances in Respiratory Disease, 1, 5–23.
8.
Papineni, R.S., Rosenthal, F.S. (1997) The size and distribution of droplets in the exhaled breath of healthy subjects. Journal of Aerosol Medicine, 10, 105–116.
9.
Almstrand, A.C., Ljungström, E., Lausmaa, J., Bake, B., Sjövall, P., Olin, A.C. (2009) Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Analytical Chemistry, 81, 662–668.
10.
Beck O., Leine K., Palmskog G., Franck J. (2010) Amphetamines detected in exhaled breath from drug addicts: a new possible method for drugs-of-abuse testing. Journal of Analytical Toxicology, 34, 233–237.
11.
Beck O., Sandqvist S., Eriksen P., Franck J., Palmskog G. (2010) Method for determination of methadone in exhaled breath collected from subjects undergoing methadone maintenance treatment. Journal of Chromatography B, 878, 2255–2259.
12.
Beck O., Sandqvist S., Eriksen P., Franck J., Palmskog G. (2011) Determination of methadone in exhaled breath condensate by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 35, 129–133.
13.
Beck O., Sandqvist S., Böttcher M., Eriksen P., Franck J., Palmskog G. (2011) Study on the sampling of methadone from exhaled breath. Journal of Analytical Toxicology, 35, 257–263.
14.
Bosker W.M., Huestis M. (2009) Oral fluid testing for drugs of abuse. Clinical Chemistry, 55, 1910-1931.
15.
Beck O., Sandqvist S., Dubbelboer I., Franck J. (2011) Detection of THC in exhaled breath collected from cannabis users. Journal of Analytical Toxicology, 35, 541–544.
16.
Beck O., Stephanson N., Sandqvist S., Franck J. (2012) Detection of drugs of abuse in exhaled breath from users following recovery from intoxication. Journal of Analytical Toxicology. 36, 638–646.
Dr. Olof Beck studied chem- istry at the Royal Institute of Technology in Stockholm and received his PhD in 1982 after working at the Karolinska Institute with
studies on biogenic amines using gas chro- matography-mass spectrometry methods. After a post-doctoral period at Stanford Uni- versity and two years in the pharmaceutical industry he returned to Karolinska Institute
and the department of Clinical Pharmacol- ogy in 1988. Dr Beck is at present adjunct professor and laboratory director of the Pharmacology Laboratory comprising TDM, genotyping, clinical and workplace drugs- of-abuse testing, sports doping control and contract analyses in clinical trials. He has been active assessor in laboratory accredita- tion in the Nordic countries.
Research activities have resulted in over 200 publications. Areas of interest are method developments in pharmacology and toxicolo- gy with special focus on mass spectrometry, alcohol biomarkers and toxicology. His most recent work has been focused on Internet drugs, breath testing for abused drugs and alcohol biomarker phosphatidylethanol.
www.datia.org
datia focus
37
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62